Meet Our Experts

Please select a topic:

Experts for: R&D Strategies

Sabine Pilari

Sabine Pilari

Expert for Pharmacometrics and PK/PD Modeling

  • PK and PK/PD analyses, including exposure-response, mechanistic, and PBPK modeling
  • Human PK prediction and estimation of efficacious & starting doses
  • Pharmacometrics analysis, population PK, and PK/PD modeling
  • Guidance on dose selection and dosing regimen optimization for clinical studies
Wolf-Stefan Richter

Wolf-Stefan Richter

Expert for Clinical Development

  • Study design and imaging biomarkers
  • Medical need assessment
  • Medical regulatory strategy
Astrid Schott

Astrid Schott

Expert for Clinical Research & Development

  • Clinical Development planning, Phase I-III
  • Interim management
  • Due Diligence, licensing
Johannes Lampe

Johannes Lampe

Expert for Clinical Research & Development

  • Clinical development, Phase I-IV (Neurology, Immunology)
  • Medical regulatory strategy
  • Due diligence
Christian Wolf

Christian Wolf

Expert for Clinical Development & Life Cycle Management

  • CNS indications (MS, epilepsy, stroke)
  • Strategy, operations and interim management
  • Business development
Frank S. Zollmann

Frank S. Zollmann

Expert for Pre-/ Clinical Drug Development

  • Safety pharmacology, toxicology, pharmacogenomics
  • Integrated preclinical & clinical development up to PoC
  • Clinical pharmacology
Daniel Sehrt

Daniel Sehrt

Expert for Early Clinical Research & Development

  • Scientific concept & design of Phase I-IIa trials
  • Clinical pharmacology (PK/PD and pharmacogenomics)
  • Clinical trial applications
Christian Hucke

Christian Hucke

  • Clinical and non-clinical Project Management
  • Interim Management, Strategy
  • Clinical Operations, Clinical Study Management
  • Quality Risk Management